Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways

NCT04349293 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris